No Cover Image

Journal article 432 views 87 downloads

Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey

Matthew Jones, Amira Guirguis Orcid Logo, Alan Watkins Orcid Logo, Ceri Bradshaw, Lily Mohamed, Fabrizio Schifano

Human Psychopharmacology: Clinical and Experimental, Volume: 38, Issue: 5

Swansea University Authors: Matthew Jones, Amira Guirguis Orcid Logo, Alan Watkins Orcid Logo, Ceri Bradshaw

  • 64608.VOR.pdf

    PDF | Version of Record

    © 2023 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley & Sons Ltd. Distributed under the terms of a Creative Commons Attribution 4.0 License (CC BY 4.0).

    Download (259.85KB)

Check full text

DOI (Published version): 10.1002/hup.2882

Abstract

Introduction: Treatment retention is associated with better outcomes and reduced risk amongst people experiencing opioid use disorder (OUD). Despite this, treatment retention remains low amongst this population. Methods: We carried out an international cross-sectional survey of substance use disorde...

Full description

Published in: Human Psychopharmacology: Clinical and Experimental
ISSN: 0885-6222 1099-1077
Published: UK Wiley 2023
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa64608
first_indexed 2023-10-19T14:19:48Z
last_indexed 2024-11-25T14:14:20Z
id cronfa64608
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2023-10-19T15:23:16.9711654</datestamp><bib-version>v2</bib-version><id>64608</id><entry>2023-09-25</entry><title>Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey</title><swanseaauthors><author><sid>d063b18627093a02f325955f76eeeb76</sid><firstname>Matthew</firstname><surname>Jones</surname><name>Matthew Jones</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b49270b9a0d580cf4f31f9a1b6c93f87</sid><ORCID>0000-0001-8255-0660</ORCID><firstname>Amira</firstname><surname>Guirguis</surname><name>Amira Guirguis</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>81fc05c9333d9df41b041157437bcc2f</sid><ORCID>0000-0003-3804-1943</ORCID><firstname>Alan</firstname><surname>Watkins</surname><name>Alan Watkins</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>8b96f170df39ac5f5af2f9354946a630</sid><firstname>Ceri</firstname><surname>Bradshaw</surname><name>Ceri Bradshaw</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2023-09-25</date><deptcode>MEDS</deptcode><abstract>Introduction: Treatment retention is associated with better outcomes and reduced risk amongst people experiencing opioid use disorder (OUD). Despite this, treatment retention remains low amongst this population. Methods: We carried out an international cross-sectional survey of substance use disorder (SUD) treatment service workers. We aimed to understand the barriers to treatment retention in the context of OUD from the provider perspective, identify differences in response preference between professional groups, and describe regional differences in treatment provision. Results: We report data from 497 respondents based in the USA and the UK. Personality disorders, low motivation to change and social problems were the most often reported obstacles to retention. Comorbid SUD, hepatitis and HIV were not reported as often as expected. We identified associations between professional groups and response preferences related to comorbid SUD, low motivation, living arrangements and communication difficulties. UK respondents used behavioural treatments more than their US counterparts. US respondents more often reported using objective methods of measuring retention such as urine analysis, compared to their UK counterparts. Discussion: The findings from this survey suggest that regional differences exist between US and UK based SUD treatment service workers. Personality disorders represented the most often experienced obstacles to treatment retention amongst patients with OUD, with mental health and social problems more often reported than comorbid drug problems or physical health problems. Statistically significant relationships exist between professional group and obstacles reported. These data may be used to identify additional training needs amongst SUD treatment service staff.</abstract><type>Journal Article</type><journal>Human Psychopharmacology: Clinical and Experimental</journal><volume>38</volume><journalNumber>5</journalNumber><paginationStart/><paginationEnd/><publisher>Wiley</publisher><placeOfPublication>UK</placeOfPublication><isbnPrint/><isbnElectronic/><issnPrint>0885-6222</issnPrint><issnElectronic>1099-1077</issnElectronic><keywords>Addictions, heroin, opioid use disorder, retention, substance use disorder treatment, survey</keywords><publishedDay>30</publishedDay><publishedMonth>9</publishedMonth><publishedYear>2023</publishedYear><publishedDate>2023-09-30</publishedDate><doi>10.1002/hup.2882</doi><url>http://dx.doi.org/10.1002/hup.2882</url><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Other</apcterm><funders>This programme of study was self-funded by the lead author.</funders><projectreference/><lastEdited>2023-10-19T15:23:16.9711654</lastEdited><Created>2023-09-25T08:05:20.4462255</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">School of Psychology</level></path><authors><author><firstname>Matthew</firstname><surname>Jones</surname><order>1</order></author><author><firstname>Amira</firstname><surname>Guirguis</surname><orcid>0000-0001-8255-0660</orcid><order>2</order></author><author><firstname>Alan</firstname><surname>Watkins</surname><orcid>0000-0003-3804-1943</orcid><order>3</order></author><author><firstname>Ceri</firstname><surname>Bradshaw</surname><order>4</order></author><author><firstname>Lily</firstname><surname>Mohamed</surname><order>5</order></author><author><firstname>Fabrizio</firstname><surname>Schifano</surname><order>6</order></author></authors><documents><document><filename>64608__28834__06d34d875f5640a395738bfcf557bb0f.pdf</filename><originalFilename>64608.VOR.pdf</originalFilename><uploaded>2023-10-19T15:20:31.6866763</uploaded><type>Output</type><contentLength>266088</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>&#xA9; 2023 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley &amp; Sons Ltd. Distributed under the terms of a Creative Commons Attribution 4.0 License (CC BY 4.0).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2023-10-19T15:23:16.9711654 v2 64608 2023-09-25 Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey d063b18627093a02f325955f76eeeb76 Matthew Jones Matthew Jones true false b49270b9a0d580cf4f31f9a1b6c93f87 0000-0001-8255-0660 Amira Guirguis Amira Guirguis true false 81fc05c9333d9df41b041157437bcc2f 0000-0003-3804-1943 Alan Watkins Alan Watkins true false 8b96f170df39ac5f5af2f9354946a630 Ceri Bradshaw Ceri Bradshaw true false 2023-09-25 MEDS Introduction: Treatment retention is associated with better outcomes and reduced risk amongst people experiencing opioid use disorder (OUD). Despite this, treatment retention remains low amongst this population. Methods: We carried out an international cross-sectional survey of substance use disorder (SUD) treatment service workers. We aimed to understand the barriers to treatment retention in the context of OUD from the provider perspective, identify differences in response preference between professional groups, and describe regional differences in treatment provision. Results: We report data from 497 respondents based in the USA and the UK. Personality disorders, low motivation to change and social problems were the most often reported obstacles to retention. Comorbid SUD, hepatitis and HIV were not reported as often as expected. We identified associations between professional groups and response preferences related to comorbid SUD, low motivation, living arrangements and communication difficulties. UK respondents used behavioural treatments more than their US counterparts. US respondents more often reported using objective methods of measuring retention such as urine analysis, compared to their UK counterparts. Discussion: The findings from this survey suggest that regional differences exist between US and UK based SUD treatment service workers. Personality disorders represented the most often experienced obstacles to treatment retention amongst patients with OUD, with mental health and social problems more often reported than comorbid drug problems or physical health problems. Statistically significant relationships exist between professional group and obstacles reported. These data may be used to identify additional training needs amongst SUD treatment service staff. Journal Article Human Psychopharmacology: Clinical and Experimental 38 5 Wiley UK 0885-6222 1099-1077 Addictions, heroin, opioid use disorder, retention, substance use disorder treatment, survey 30 9 2023 2023-09-30 10.1002/hup.2882 http://dx.doi.org/10.1002/hup.2882 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Other This programme of study was self-funded by the lead author. 2023-10-19T15:23:16.9711654 2023-09-25T08:05:20.4462255 Faculty of Medicine, Health and Life Sciences School of Psychology Matthew Jones 1 Amira Guirguis 0000-0001-8255-0660 2 Alan Watkins 0000-0003-3804-1943 3 Ceri Bradshaw 4 Lily Mohamed 5 Fabrizio Schifano 6 64608__28834__06d34d875f5640a395738bfcf557bb0f.pdf 64608.VOR.pdf 2023-10-19T15:20:31.6866763 Output 266088 application/pdf Version of Record true © 2023 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley & Sons Ltd. Distributed under the terms of a Creative Commons Attribution 4.0 License (CC BY 4.0). true eng https://creativecommons.org/licenses/by/4.0/
title Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey
spellingShingle Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey
Matthew Jones
Amira Guirguis
Alan Watkins
Ceri Bradshaw
title_short Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey
title_full Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey
title_fullStr Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey
title_full_unstemmed Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey
title_sort Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey
author_id_str_mv d063b18627093a02f325955f76eeeb76
b49270b9a0d580cf4f31f9a1b6c93f87
81fc05c9333d9df41b041157437bcc2f
8b96f170df39ac5f5af2f9354946a630
author_id_fullname_str_mv d063b18627093a02f325955f76eeeb76_***_Matthew Jones
b49270b9a0d580cf4f31f9a1b6c93f87_***_Amira Guirguis
81fc05c9333d9df41b041157437bcc2f_***_Alan Watkins
8b96f170df39ac5f5af2f9354946a630_***_Ceri Bradshaw
author Matthew Jones
Amira Guirguis
Alan Watkins
Ceri Bradshaw
author2 Matthew Jones
Amira Guirguis
Alan Watkins
Ceri Bradshaw
Lily Mohamed
Fabrizio Schifano
format Journal article
container_title Human Psychopharmacology: Clinical and Experimental
container_volume 38
container_issue 5
publishDate 2023
institution Swansea University
issn 0885-6222
1099-1077
doi_str_mv 10.1002/hup.2882
publisher Wiley
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str School of Psychology{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}School of Psychology
url http://dx.doi.org/10.1002/hup.2882
document_store_str 1
active_str 0
description Introduction: Treatment retention is associated with better outcomes and reduced risk amongst people experiencing opioid use disorder (OUD). Despite this, treatment retention remains low amongst this population. Methods: We carried out an international cross-sectional survey of substance use disorder (SUD) treatment service workers. We aimed to understand the barriers to treatment retention in the context of OUD from the provider perspective, identify differences in response preference between professional groups, and describe regional differences in treatment provision. Results: We report data from 497 respondents based in the USA and the UK. Personality disorders, low motivation to change and social problems were the most often reported obstacles to retention. Comorbid SUD, hepatitis and HIV were not reported as often as expected. We identified associations between professional groups and response preferences related to comorbid SUD, low motivation, living arrangements and communication difficulties. UK respondents used behavioural treatments more than their US counterparts. US respondents more often reported using objective methods of measuring retention such as urine analysis, compared to their UK counterparts. Discussion: The findings from this survey suggest that regional differences exist between US and UK based SUD treatment service workers. Personality disorders represented the most often experienced obstacles to treatment retention amongst patients with OUD, with mental health and social problems more often reported than comorbid drug problems or physical health problems. Statistically significant relationships exist between professional group and obstacles reported. These data may be used to identify additional training needs amongst SUD treatment service staff.
published_date 2023-09-30T05:26:06Z
_version_ 1821291332968120320
score 11.047306

Similar Items